These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 17045743)

  • 1. Peripheral blood mononuclear cell supernatants from asymptomatic dogs immunized and experimentally challenged with Leishmania chagasi can stimulate canine macrophages to reduce infection in vitro.
    Rodrigues CA; Batista LF; Teixeira MC; Pereira AM; Santos PO; de Sá Oliveira GG; de Freitas LA; Veras PS
    Vet Parasitol; 2007 Feb; 143(3-4):197-205. PubMed ID: 17045743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
    Strauss-Ayali D; Baneth G; Shor S; Okano F; Jaffe CL
    Int J Parasitol; 2005 Jan; 35(1):63-73. PubMed ID: 15619517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis.
    Holzmuller P; Cavaleyra M; Moreaux J; Kovacic R; Vincendeau P; Papierok G; Lemesre JL
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):247-57. PubMed ID: 15963823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis.
    Chamizo C; Moreno J; Alvar J
    Vet Immunol Immunopathol; 2005 Jan; 103(1-2):67-75. PubMed ID: 15626462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
    Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
    Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs.
    Saldarriaga OA; Travi BL; Park W; Perez LE; Melby PC
    Vaccine; 2006 Mar; 24(11):1928-40. PubMed ID: 16310897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.
    Pinelli E; Gonzalo RM; Boog CJ; Rutten VP; Gebhard D; del Real G; Ruitenberg EJ
    Eur J Immunol; 1995 Jun; 25(6):1594-600. PubMed ID: 7614987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis.
    Reis AB; Giunchetti RC; Carrillo E; Martins-Filho OA; Moreno J
    Trends Parasitol; 2010 Jul; 26(7):341-9. PubMed ID: 20488751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis.
    Carrillo E; Crusat M; Nieto J; Chicharro C; Thomas Mdel C; Martínez E; Valladares B; Cañavate C; Requena JM; López MC; Alvar J; Moreno J
    Vaccine; 2008 Mar; 26(15):1902-11. PubMed ID: 18321614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant cysteine proteinase from Leishmania (Leishmania) chagasi as an antigen for delayed-type hypersensitivity assays and serodiagnosis of canine visceral leishmaniasis.
    Pinheiro PH; Pinheiro AN; Ferreira JH; Costa FA; Katz S; Barbiéri CL
    Vet Parasitol; 2009 May; 162(1-2):32-9. PubMed ID: 19269098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune.
    Araújo MS; de Andrade RA; Sathler-Avelar R; Teixeira-Carvalho A; Andrade MC; Vianna LR; Mayrink W; Reis AB; Malaquias LC; Mello MN; Martins-Filho OA
    Vaccine; 2009 Feb; 27(7):1008-17. PubMed ID: 19110023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished CD4+/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis.
    de Lima VM; Ikeda FA; Rossi CN; Feitosa MM; Vasconcelos RO; Nunes CM; Goto H
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):296-302. PubMed ID: 20132994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro binding and survival assays of Leishmania parasites to peripherical blood monocytes and monocyte-derived macrophages isolated from dogs naturally and experimentally infected with Leishmania (Leishmania) chagasi.
    Sampaio WM; Moura EP; Arruda FC; Ribeiro RR; Alves CF; Melo FA; Fernandes AP; Michalick MS; Melo MN; Tafuri WL; Tafuri WL
    BMC Vet Res; 2007 May; 3():11. PubMed ID: 17537246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal analysis of cytokine gene expression and parasite load in PBMC in Leishmania infantum experimentally infected dogs.
    Sanchez-Robert E; Altet L; Alberola J; Rodriguez-Cortés A; Ojeda A; López-Fuertes L; Timon M; Sanchez A; Francino O
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):168-75. PubMed ID: 18514330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes.
    Panaro MA; Acquafredda A; Lisi S; Lofrumento DD; Mitolo V; Sisto M; Fasanella A; Trotta T; Bertani F; Consenti B; Brandonisio O
    Comp Immunol Microbiol Infect Dis; 2001 Jul; 24(3):187-95. PubMed ID: 11440191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenicity of a whole parasite vaccine as promising candidate against canine leishmaniasis.
    Giunchetti RC; Reis AB; da Silveira-Lemos D; Martins-Filho OA; Corrêa-Oliveira R; Bethony J; Vale AM; da Silva Quetz J; Bueno LL; França-Silva JC; Nascimento E; Mayrink W; Fujiwara RT
    Res Vet Sci; 2008 Aug; 85(1):106-12. PubMed ID: 17950391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine.
    Saraiva EM; de Figueiredo Barbosa A; Santos FN; Borja-Cabrera GP; Nico D; Souza LO; de Oliveira Mendes-Aguiar C; de Souza EP; Fampa P; Parra LE; Menz I; Dias JG; de Oliveira SM; Palatnik-de-Sousa CB
    Vaccine; 2006 Mar; 24(13):2423-31. PubMed ID: 16386824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine gene expression in the tissues of dogs infected by Leishmania infantum.
    Barbosa MA; Alexandre-Pires G; Soares-Clemente M; Marques C; Rodrigues OR; De Brito TV; Da Fonseca IP; Alves LC; Santos-Gomes GM
    J Comp Pathol; 2011 Nov; 145(4):336-44. PubMed ID: 21511273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.